- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy ; volume:24 ; number:1 ; day:6 ; month:8 ; year:2024 ; pages:1-14 ; date:12.2024
Clinical and experimental medicine ; 24, Heft 1 (6.8.2024), 1-14, 12.2024
- Creator
-
Rehman, Maheen
Qaiser, Ariba
Khan, Hassan Sardar
Manzoor, Sobia
Ashraf, Javed
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-024-01442-9
- URN
-
urn:nbn:de:101:1-2410262113442.136736164507
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rehman, Maheen
- Qaiser, Ariba
- Khan, Hassan Sardar
- Manzoor, Sobia
- Ashraf, Javed
- SpringerLink (Online service)
Other Objects (12)
The role of MSCs and CAR-MSCs in cellular immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
New cell sources for CAR-based immunotherapy
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Armed T cells with CAR for cancer immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
Enhancing in-car prediction by Car2X communication
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
The role of MSCs and CAR-MSCs in cellular immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
New cell sources for CAR-based immunotherapy
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Armed T cells with CAR for cancer immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
Enhancing in-car prediction by Car2X communication
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
The role of MSCs and CAR-MSCs in cellular immunotherapy
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
New cell sources for CAR-based immunotherapy
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Armed T cells with CAR for cancer immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
Enhancing in-car prediction by Car2X communication
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer